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Abstract
This study evaluated whether the use of continuous positive airway pressure (CPAP) in the delivery room alters the need for
mechanical ventilation and surfactant during the first 5 days of life and modifies the incidence of respiratory morbidity and
mortality during the hospital stay. The study was a multicenter randomized clinical trial conducted in five public university
hospitals in Brazil, from June 2008 to December 2009. Participants were 197 infants with birth weight of 1000-1500 g and
without major birth defects. They were treated according to the guidelines of the American Academy of Pediatrics (APP).
Infants not intubated or extubated less than 15 min after birth were randomized for two treatments, routine or CPAP, and were
followed until hospital discharge. The routine (n=99) and CPAP (n=98) infants studied presented no statistically significant
differences regarding birth characteristics, complications during the prenatal period, the need for mechanical ventilation during
the first 5 days of life (19.2 vs 23.4%, P=0.50), use of surfactant (18.2 vs 17.3% P=0.92), or respiratory morbidity and
mortality until discharge. The CPAP group required a greater number of doses of surfactant (1.5 vs 1.0, P=0.02). When CPAP
was applied to the routine group, it was installed within a median time of 30 min. We found that CPAP applied less than 15 min
after birth was not able to reduce the need for ventilator support and was associated with a higher number of doses of
surfactant when compared to CPAP applied as clinically indicated within a median time of 30 min.
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Introduction
Prematurity has a great impact on health indicators. In
Brazil, according to official reports, premature infants
weighing less than 1500 g represented 31.6% of infant
mortality cases in the country and 41.1% of the cases of
early infant mortality (1).
Diseases involving the respiratory apparatus are the
most important incurrences during the neonatal period,
especially among preterm patients. In preterm infants,
both immature development of the airways and chest and
limited surfactant secretion result in a strong tendency to
lung collapse with restriction of residual functional
capacity (2).
In an attempt to prevent the injuries caused by
mechanical ventilation, there has been a search for less
aggressive ways of promoting respiratory support for
these patients (3,4). The use of continuous positive
airway pressure (CPAP) has been pointed out as a
suitable option to prevent loss of pulmonary volume and
to minimize the use of mechanical ventilation and of
surfactant. In theory, the earlier that CPAP is applied, the
lower the tendency for loss of residual functional capacity,
and the easier the respiratory stabilization of preterm
infants (5,6). However, results obtained thus far are
contradictory (7,8) and suggest that success of this
method is related to the type of assisted population and
to the experience of the medical team (9-12).
Thus, the objective of the present study was to assess
the efficacy and repercussions of CPAP applied early to
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newborn infants weighing 1000 to 1500 g. The hypothesis
raised is that the early use of CPAP reduces the need for
mechanical ventilation and surfactant during the first 5
days of life, leading to a lower incidence of respiratory
morbidity and mortality during the hospital stay.
Material and Methods
A prospective randomized clinical study was con-
ducted at five public university hospitals from June 2008
to December 2009. The protocol was approved by the
Ethics Committees of the institutions (No. 3866/2005) and
registered at ClinicalTrials.gov.br (ID NCT01024361).
All premature newborns with a birth weight of 1000 to
1500 g without major malformations were considered
eligible for the study, independent of gestational age.
Parents gave written informed consent for participation
before the infant’s birth. Infants with major congenital
anomalies or fetal hydrops diagnosed after birth were
excluded. Only the first twin was included.
Patients received support from the local neonatology
team according to the 2005 guidelines of the American
Academy of Pediatrics (AAP) and American Heart
Association (AHA) (13).
Immediately after birth, infants were placed in a
porous plastic bag, the airways were aspirated, and heart
rate, respiratory effort, and color were evaluated. When
the heart rate was lower than 100 bpm or the patient did
not show rhythmic and regular spontaneous breathing,
ventilation was maintained with a manual ventilator and
mask (NeopuffTM Infant Resuscitator, Fisher & Paykel
Healthcare Corporation Limited, New Zealand), for 30 s,
and the patient was then reevaluated.
If the patient continued to be in apnea or to breathe
irregularly, he was intubated and ventilated with a
NeopuffTM manual ventilator with positive end-expiratory
pressure (PEEP) at 5 cmH2O and with inspiratory
pressure sufficient to obtain a maximum thoracic insuffla-
tion of 0.5 cm, a frequency of 40 movements per minute,
and 100% oxygen. If the newborn established sponta-
neous rhythmic respiration within less than 15 min, he
was extubated and eligible for the study.
Infants not intubated or extubated less than 15 min
after birth were randomized for two treatments: routine or
CPAP. When an infant randomized for routine treatment
presented central cyanosis, oxygen was started according
to the techniques recommended by the guidelines of the
AAP and AHA (13). When randomized to CPAP, positive
pressure was applied using a NeopuffTM manual ventilator
with PEEP at 5 cmH2O and 100% oxygen. Newborns
were transferred to the Neonatal Intensive Care Unit,
where, after stabilization, ventilation parameters followed
institutional protocols. The CPAP group was maintained
with positive pressure for at least 48 h.
Randomization was performed previously for two
weight strata (1000-1250 and 1251-1500 g) in blocks of
four for CPAP treatment or routine treatment in a 1:1 ratio,
and the cards were placed in opaque sealed envelopes.
The maternal variables evaluated were: age, number
of prenatal visits, time since rupture of the membranes,
gestational hypertension, diabetes, and use of an
antenatal corticoid (any dose). The neonatal variables
were: birth weight, gestational age, adequacy for gesta-
tional age (14), gender, use of mask ventilation in the
delivery room, intubation in the delivery room, need for
cardiac massage, SNAPPE-II (15), first- and fifth-minute
Apgar score, and other intercurrences observed during
hospitalization such as apnea, pneumonia, pulmonary
hemorrhage, pneumothorax, atelectasis, the need for
mechanical ventilation, surfactant and oxygen, and death.
The primary end points were the need for mechanical
ventilation and/or surfactant during the first 5 days of life,
and secondary outcomes were the incidences of respira-
tory morbidity and mortality during the hospital stay.
Sample size was calculated as 98 infants per group,
based on the supposition that intervention would lead to a
20% reduction in the rates of mechanical ventilation, with
a two-tailed type I error of 0.05 and 80% power.
Continuous variables with a normal distribution were
analyzed by the Student t-test, and variables without a
normal distribution were analyzed by the Mann-Whitney
test. Qualitative variables were analyzed by the Fisher
exact test.
Results
A total of 256 infants were considered eligible for the
study from June 2008 to December 2009. Of these, 59
were excluded, 42 of them due to the fact that informed
consent was not given on time, 10 because their CPAP
did not become ready on time, and 7 because their
parents refused to participate. Thus, a total of 197
patients were included in the study: 99 assigned to the
routine group and 98 to the CPAP group. After inclusion,
no infant was excluded from analysis.
The antenatal conditions of the two groups were
similar and are reported in Table 1. There was a high
occurrence of maternal hypertension and a low percent-
age of use of antenatal corticoid.
The main birth characteristics of the infants included in
the study are reported in Table 2. There was no significant
difference between groups.
There was no difference between groups regarding
the need for mechanical ventilation during the first 5 days
of life (Table 3). The CPAP group required a greater
number of surfactant doses. Sixty percent of the infants
submitted to routine treatment received CPAP due to
clinical indication by the medical team at a median time of
30 min of life.
There was no difference between the randomized
infants during hospitalization regarding respiratory mor-
bidity and mortality. The occurrence of apnea was high in
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both groups (33.6% in the CPAP group and 42.4% in the
routine group).
Discussion
Several alternatives have been proposed to minimize
lung injury in preterm infants, one of them being the early
application of CPAP, although there are doubts about its
efficacy (9-12).
The early CPAP system became a subject of study
after a publication in 1987 by Avery et al. (16) had shown
a significantly lower incidence of the use of oxygen in
newborns at 28 days at Columbia University compared to
major American hospitals. The center in question differed
from the others by using early CPAP (16).
The initial hypothesis of the present study was that,
with early application of distention pressure, alveolar
collapse would be reduced, with a consequent lower
consumption of surfactant and a less frequent need for
mechanical ventilation. However, in contrast to expecta-
tions, no significant difference was detected regarding the
need for mechanical ventilation. In addition, the early
CPAP group required a greater number of surfactant
doses. Several factors may have influenced these
findings.
Although the maternal population of the preterm
infants studied was comparable, these patients were at
high obstetrical and neonatal risk (Table 1). In this
population, the incidence of gestational hypertension
was high, about 45%, as opposed to values of 10 to
13% for all pregnancies reported in the Brazilian literature
(17). The occurrence of gestational hypertensive disease
involves important perinatal implications such as prema-
turity, fetal growth restriction, and fetal distress. Although
hypertension is believed to accelerate lung maturation, a
study by the Brazilian Neonatal Network regarding risk
factors for mortality in premature patients reported that
hypertension was associated with the risk of death (18).
Also, the use of antenatal corticosteroid was low,
occurring in about 65% of cases, despite more than 90%
of the mothers having had at least two prenatal visits. In
developed countries, antenatal corticosteroid is used in
a much higher percentage of patients, usually above
80% (9,10). This fact is extremely relevant for the
characterization of a population, because antenatal use
of a corticosteroid proved to reduce the occurrence of
Table 1. Antenatal conditions according to the randomized groups.
CPAP (n=98) Routine (n=99)
Maternal age (years) 27.5 ± 7.2 25.5 ± 6.6
Prenatal (.2 visits) 92 (93.8%) 93 (93.9%)
Antenatal corticosteroids (any dose) 66 (67.3%) 63 (63.6%)
Maternal hypertension 46 (46.9%) 44 (44.4%)
Gestational diabetes 8 (8.1%) 7 (7.1%)
Rupture of membranes (h) 0 (0-216) 0 (0-720)
Cesarean section 82 (83.6%) 79 (79.8%)
Data are reported as means±SD, number (%), and median (range). CPAP: continuous positive airway pressure. There were no
significant differences between groups (Mann-Whitney test).
Table 2. Main characteristics of the preterm infants included in the study.
CPAP Routine
Birth weight (g) 1262 ± 147 1286 ± 140
Gestational age (weeks) 31.2 ± 2.2 31.2 ± 2.2
Small for gestational age 12 (12.2%) 14 (14.1%)
Female 54 (55.1%) 48 (48.4%)
Mask ventilation in the delivery room 48 (48.9%) 44 (44.4%)
Intubation in the delivery room 6 (6.1%) 1 (1.0%)
Apgar score at 1st min 6.59 ± 2.1 6.95 ± 2.1
Apgar score at 5th min 9.05 ± 0.9 8.95 ± 1.0
SNAPPE-II 10.3 ± 9.0 8.14 ± 8.8
Data are reported as means±SD and number (%). CPAP: continuous positive airway pressure; SNAPPE-II: Score for Neonatal Acute
Physiology (SNAP) and SNAP Perinatal Extension. There were no significant differences between groups (Mann-Whitney test).
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respiratory distress syndrome, of peri- and intraventricular
hemorrhage, and of neonatal mortality among preterm
infants (19). The lack of administration of an antenatal
corticoid is a risk factor for CPAP failure (20,21).
As presented in Table 2, no significant differences
among the characteristics of the neonates were detected.
The patients presented optimal birth conditions, with a
mean first-minute Apgar score of 6 and a fifth-minute
score of 9, indicating sufficient conditions for the installa-
tion of the CPAP system in the delivery room. It is
interesting to observe that approximately 45% of the
patients required a balloon and mask ventilation before
the installation of CPAP, and only 3.5% of the premature
infants required intubation in the delivery room. In other
words, almost one-half the infants of the CPAP group,
who were supposed to receive the least possible
detrimental ventilation, were previously submitted to bag
ventilation, in which there is no control of the tidal volume
or pressure offered. Despite the previous ventilation with
bag and mask, it was possible to install CPAP in the
delivery room.
Finer et al. (7) reported a 73% requirement of
ventilation with positive pressure before the early installa-
tion of CPAP in a sample consisting of neonates born with
less than 28 weeks of gestation and, among them, 49% of
those selected for intervention required intubation in the
delivery room. Before randomization, no statistical differ-
ences were observed. On the other hand, the random
adjustment revealed six intubated infants in the CPAP
group vs one in the routine group, and the SNAPPE-II was
two points higher in the CPAP group. These data may be
indicative of a discrete greater clinical severity in the
infants belonging to the CPAP group at selection.
Prophylactic CPAP was also associated with a greater
number of surfactant doses (median 1.5 vs 1.0, P=0.02).
The median time of administration of the first surfactant
dose was also greater in the CPAP group, although the
difference was not statistically significant. Perhaps post-
poning the time of administration of the first dose may
have led to a worsening of the hyaline membrane
situation, with the consequent need for a greater number
of surfactant doses (22). Therefore, the clinical signifi-
cance of the differences should be considered. Another
point that should be emphasized is that the use of CPAP
occurred in 60% of cases in the routine group, whereas,
obviously, it occurred in 100% of cases in the CPAP
group. It is possible that 40% of the CPAP group
unnecessarily received the pressure support. It has been
reported that CPAP can also lead to injury, with a lower,
but not negligible, potential than standard mechanical
ventilation. (4) Thus, applying CPAP prophylactically to
patients before the installation of respiratory discomfort
may have caused pulmonary inflammation and a con-
sequent greater need for a surfactant. The discrete
greater clinical severity of the CPAP group may also be,
at least in part, responsible for the differences.
CPAP was applied early to the routine group, with a
median time of 30 min (Table 3). The time of installation of
prophylactic CPAP varies in the literature, with reports of
15 min (5) or up to 2 h (8). The early installation of CPAP
in the routine group may have contributed to the
occurrence of similar results in the two groups. These
data suggest that perhaps it may not be necessary to
install CPAP in the delivery room if there is the possibility
of offering it early in the intensive care unit.
Approximately 20% of the infants in both groups
required mechanical ventilation during the first 5 days of
life, with a median starting time of 135 min for the routine
group and of 202 min for the CPAP group. These data are
slightly worse than the 12% indication of mechanical
ventilation found in the Italian population where about
83% received antenatal corticosteroids (8). The applica-
tion of CPAP during the first 15 min of life to infants from
pregnancies with a high incidence of obstetrical disease
and a low use of antenatal corticosteroid was not
sufficient to modify the profile of ventilator assistance for
the patients.
The use of 2005 resuscitation guidelines (13) can be
considered a limitation of this study. It would be
interesting to evaluate whether improved oxygen control
Table 3. Need for mechanical ventilation and use of a surfactant during the first 5 days of life according to study group.
CPAP Routine
Mechanical ventilation 23 (23.4%) 19 (19.2%)
Start of mechanical ventilation (min) 202 (32-5760) 135 (30-4320)
Use of a surfactant 17 (17.3%) 18 (18.2%)
Application of the 1st surfactant dose (min) 420 (67-1415) 120 (24-1020)
Surfactant doses 1.5 (1-3)* 1.0 (1-2)
Use of CPAP 98 (100%) 60 (60.1%)a
Time for initiation of CPAP (min) 15 (1-15)* 30 (10-420)
Data are reported as number (%) and median (range). aClinical indication in the ICU. CPAP: continuous positive airway pressure.
* P,0.05, compared to routine (Mann-Whitney test).
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recommended in the new 2010 guidelines (23) would
impact the results. However, studies on the subject
conducted to date have used the same standards as in
the present study (7,8,11,12), and controlling the supply
of oxygen as recommended in the 2010 guidelines is
unfortunately not yet a reality for all centers of neonatal
assistance in developing countries. Another change in
2010 was the guideline for temperature control in
premature infants, not recorded in this study, because
we have no data on the temperature of the patients, which
was another limitation of this study. Another limitation of
the study was the time of application of CPAP in the
routine group, which, as clinically indicated, ended up
being very similar to the study group.
Our new findings are that applying CPAP within the
first 15 min of life in the delivery room causes the same
effects as applying CPAP at 30 min in the neonatal unit. In
conclusion, CPAP applied less than 15 min after birth was
not able to reduce the need for ventilator support. It was
associated with a higher number of doses of surfactant,
when compared to CPAP applied as clinically indicated,
with a median time of 30 min for 1000-1500 g newborns.
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